CD274 and breast carcinoma: In particular, clinically observed survival trends in TACS1→TACS2→TACS3 and TACS1→TACS2 cases in breast cancer were only explained in our modelling framework by incorporating additional phenotypic adaptation mechanisms, including EMT and increased PD-L1 expression [18].